Skip to content
value.today

Neuralstem, Inc.

Total raised
$2 M
1 round on record
Latest round
$2 M
Dec 2009
First round on record
Dec 2009
Today
Went public
See the company page

Neuralstem, Inc. is listed today as Palisade Bio, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 10 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Neuralstem, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2024$4 MPrivate placement after listing$2 to $10 million

Neuralstem, Inc.: Private sale, May 2024

Investors in this round

1 investor had bought by the notice of May 10, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$309,999
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • J.D. Finley · Executive Officer, Director
  • Mitchell Jones · Executive Officer
  • Binxian Wei · Director
  • Donald Williams · Director
  • Margery Fischbein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 000000505) · New York, New YorkSold in CA, CT, FL, IL, NV, NY, TX

Remarks in the notice

  • On fees: “Sales commissions does not include warrant to purchase 36,914 shares to placement agent and $60,000 in expenses reimbursed.”
  • On the amounts: “(i) 85,100 shares and 530,142 prefunded warrants and (ii)922,863 seven year warrants sold in offering at $6.5015 per unit”

Signed by J.D. Finley, Ceo. Source: SEC Form D, newest notice filed May 10, 2024. Read the notice at the SEC.

equity, optionsSEC
Feb 2024$3 MPrivate placement after listing$2 to $10 million

Neuralstem, Inc.: Private sale, Feb 2024

Investors in this round

15 investors had bought by the notice of Feb 13, 2024: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$193,960
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • J.D. Finley · Executive Officer, Director
  • Mitchell Jones · Executive Officer
  • Binxian Wei · Director
  • Donald Williams · Director
  • Mary Ann Gray · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in IL, NV, NY

Remarks in the notice

  • On fees: “Sales commissions does not include a warrant to purchase 205,337 shares issued to placement agent”

Signed by J.D. Finley, Ceo. Source: SEC Form D, newest notice filed Feb 13, 2024. Read the notice at the SEC.

optionsSEC
Apr 2023$4 MPrivate placement after listing$2 to $10 million

Neuralstem, Inc.: Private sale, Apr 2023

Investors in this round

9 investors had bought by the notice of Apr 10, 2023: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: 455,242 Shares, 1,061,164 Prefunded Warrants, 2,272,723 Warrants, and 136,636 Placement Agent Warrants
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$310,256
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Herbert Slade · Executive Officer
  • J.D. Finley · Executive Officer, Director
  • Robert McRae · Executive Officer
  • Binxian Wei · Director
  • Cristina Csimma · Director
  • Donald Williams · Director
  • James Neal · Director
  • Mary Ann Gray · Director
  • Robert Trenschel · Director
  • Stephanie Diaz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in CA, IL, MN, NE, NJ, NY

Remarks in the notice

  • On fees: “Private Placement portion of Offering. Does not include (i) expenses or (ii) Placement warrants.”
  • On the amounts: “Represents the unregistered Shares and prefunded warrants issued in private placement portion of offering”

Signed by J.D. Finley, Interim CEO. Source: SEC Form D, newest notice filed Apr 10, 2023. Read the notice at the SEC.

equity, optionsSEC
Jan 2023$3 MPrivate placement after listing$2 to $10 million

Neuralstem, Inc.: Private sale, Jan 2023

Investors in this round

6 investors had bought by the notice of Jan 19, 2023: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them, other: Includes 538,789 Pre-funded Warrants, 1,052,631 Warrants, and 63,158 Representative Warrants
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$193,750
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • J.D. Finley · Executive Officer
  • Binxian Wei · Director
  • Cristina Csimma · Director
  • Donald Williams · Director
  • James Neal · Director
  • Mary Ann Gray · Director
  • Robert Trenschel · Director
  • Stephanie Diaz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in IL, NV, NY

Remarks in the notice

  • On fees: “Does not include (i) expense reimbursement or (ii) placement agent warrants”

Signed by J.D. Finley, Interim CEO. Source: SEC Form D, newest notice filed Jan 19, 2023. Read the notice at the SEC.

optionsSEC
May 2022$2 MPrivate placement after listing$2 to $10 million

Neuralstem, Inc.: Private sale, May 2022

Investors in this round

5 investors had bought by the notice of May 20, 2022: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$310,898
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • JD Finley · Executive Officer
  • Thomas Hallam · Executive Officer, Director
  • Binxian C Wei · Director
  • Cristina C Csimma · Director
  • Donald C Williams · Director
  • James R Neal · Director
  • Mary Ann C Gray · Director
  • Robert C Trenschel · Director
  • Stephanie C Diaz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in CT, IL, NY

Remarks in the notice

  • On fees: “Includes cash commissions in the amount of $155,440 and the balance represents the aggregate exercise price of warrants to purchase shares of common stock issued to the placement agent”
  • On the amounts: “Represents warrants to purchase shares of Common Stock issued to the purchasers and the placement agent; such warrants have not yet been exercised.”

Signed by JD Finley, Chief Financial Officer. Source: SEC Form D, newest notice filed May 20, 2022. Read the notice at the SEC.

optionsSEC
Jan 2020$8 MPrivate placement after listing$2 to $10 million

Neuralstem, Inc.: Private sale, Jan 2020

Investors in this round

3 investors had bought by the notice of Jan 28, 2020: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$604,444
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth Carter · Executive Officer, Director
  • Binxian Wei · Director
  • Cristina Csimma · Director
  • David Mazzo · Director
  • Mary Ann Gray · Director
  • Sandford Smith · Director
  • Scott Ogilvie · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co. LLC (CRD 375) · New York, New YorkSold in FL, NJ, NY

Remarks in the notice

  • On fees: “Does not include (i) management fees, (ii) non-accountable expenses, (iii) legal reimbursement and (vi) placement agent warrants”
  • On the amounts: “common stock warrants were issued for exercising existing warrants at a reduced price pursuant to a warrant exercise agreement”

Signed by Kenneth Carter, Executive Chairman. Source: SEC Form D, newest notice filed Jan 28, 2020. Read the notice at the SEC.

optionsSEC
Dec 2016$20 MPrivate placement after listing$10 to $50 million

Neuralstem, Inc.: Private sale, Dec 2016

Investors in this round

1 investor had bought by the notice of Dec 19, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
$20,000,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Lloyd Jones · Executive Officer
  • Richard Daly · Executive Officer, Director
  • Catherine Sohn · Director
  • Sandford Smith · Director
  • Scott Ogilvie · Director
  • Stanley Westreich · Director
  • William Oldaker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard Daly, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 19, 2016. Read the notice at the SEC.

equitySEC
May 2016$1 MPrivate placement after listingUnder $2 million

Neuralstem, Inc.: Private sale, May 2016

Investors in this round

3 investors had bought by the notice of May 23, 2016: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$50,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Lloyd Jones · Executive Officer
  • Karl Johe · Executive Officer, Director
  • Richard Daly · Executive Officer, Director
  • Catherine Sohn · Director
  • Richard Garr · Director
  • Sandford Smith · Director
  • Scott Ogilvie · Director
  • Stanley Westreich · Director
  • William Oldaker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On fees: “Financial advisory fee of $50,000 was paid to Roth Capital Partners, LLC”
  • On the amounts: “For every share purchased at a price of $0.40 per share, each investor received a warrant to purchase one share of common stock at an exercise price of $0.40 and a term of five years.”

Signed by Richard Daly, Chief Executive Officer. Source: SEC Form D, newest notice filed May 23, 2016. Read the notice at the SEC.

equity, optionsSEC
Oct 2014$10 MPrivate placement after listing$10 to $50 million

Neuralstem, Inc.: Private sale, Oct 2014

Investors in this round

1 investor had bought by the notice of Dec 4, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$77,327
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • I. Richard Garr · Executive Officer, Director
  • Karl Richard Johe · Executive Officer, Director
  • Catherine A. Sohn · Director
  • Sandford D. Smith · Director
  • Scott Richard Ogilvie · Director
  • Stanley Richard Westreich · Director
  • William Richard Oldaker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Tripoint Global Equities, LLC (CRD 143174) · New York, New YorkSold in CA

Remarks in the notice

  • On fees: “Amount does not include 28,119 common shares and 58,141 common stock purchase warrants issued as Sales Commissions.”
  • On the amounts: “Total offering amount represents an amendment to an outstanding loan. Of this amount, $4,313,888 was received as additional new capital, $5,581,292 was used to refinance the outstanding loan balance, and $104,820 was used for transaction expenses”

Signed by I. Richard Garr, CEO, President. Source: SEC Form D and 1 amendment, newest notice filed Dec 4, 2014. Read the notice at the SEC.

debt, optionsSEC
Mar 2013$2 MPrivate placement after listingUnder $2 million

Neuralstem, Inc.: Private sale, Mar 2013

Investors in this round

3 investors had bought by the notice of Apr 10, 2013: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$280,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Karl I. Johe · Executive Officer, Director
  • Richard I. Garr · Executive Officer, Director
  • Scott I. Ogilvie · Director
  • Stanley I. Westreich · Director
  • William I. Oldaker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • TriPoint Global Equities, LLC (CRD 143174) · New York, New YorkSold in CA

Remarks in the notice

  • On fees: “Does not include payment to placement agent in common stock taken in lieu of cash, or warrant to purchase shares of common stock as described in Item 13 above.”
  • On the amounts: “Pursuant to 10MM Loan, Securities: (i) Lender common warrant (648,808 shares), (ii) Placement Agent common warrant (648,798 shares), (iii) Placement Agent: 259,740 common shares, (iv) Prior Underwriter: 90,010 common shares (right of first refusal)”

Signed by I. Richard Garr, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 10, 2013. Read the notice at the SEC.

equity, debt, optionsSEC
Dec 2009$2 MNo. 1Under $2 million

Neuralstem, Inc.: Raise no. 1, Dec 2009

Investors in this round

1 investor had bought by the notice of Jan 5, 2010: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1,500,000
What was sold
equity
Exemption claimed
  • Rule 505: the former limited-offering exemption (withdrawn in 2017)
  • 46
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Conron · Executive Officer
  • Karl Johe · Director, Executive Officer
  • Richard Garr · Director, Executive Officer
  • Scott Ogilvie · Director
  • William Oldaker · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds from the offering will be used for the Company's general working capital needs which may include the payment of salaries and fees to officers and directors.”

Signed by I. Richard Garr, Ceo. Source: SEC Form D, newest notice filed Jan 5, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Neuralstem, Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • Revenue range over time, as stated in its notices: no revenue in 2010; revenue of up to $1 million in 2013.

    SEC Form D (revenue range) · Apr 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2024

Products and services#

No products or services of Neuralstem, Inc. are on record.

Investors#

No investor of Neuralstem, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 1 investors.

Largest shareholders today

Institutions holding Palisade Bio, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Neuralstem, Inc.
NameRoleNamed in
J.D. FinleyExecutive officerMay 2024
Mitchell JonesExecutive officerMay 2024
Herbert SladeExecutive officerApr 2023
Robert McRaeExecutive officerApr 2023
JD FinleyExecutive officerMay 2022
Thomas HallamExecutive officerMay 2022
Kenneth CarterExecutive officerJan 2020
Jonathan Lloyd JonesExecutive officerDec 2016
Richard DalyExecutive officerDec 2016
Karl JoheExecutive officerMay 2016
I. Richard GarrExecutive officerDec 2014
Karl Richard JoheExecutive officerDec 2014
Karl I. JoheExecutive officerApr 2013
Richard I. GarrExecutive officerApr 2013
John ConronExecutive officerJan 2010
Richard GarrExecutive officerJan 2010
Binxian WeiDirectorMay 2024
Donald WilliamsDirectorMay 2024
J.D. FinleyDirectorMay 2024
Margery FischbeinDirectorMay 2024
Mary Ann GrayDirectorFeb 2024
Cristina CsimmaDirectorApr 2023
James NealDirectorApr 2023
Robert TrenschelDirectorApr 2023
Stephanie DiazDirectorApr 2023
Binxian C WeiDirectorMay 2022
Cristina C CsimmaDirectorMay 2022
Donald C WilliamsDirectorMay 2022
James R NealDirectorMay 2022
Mary Ann C GrayDirectorMay 2022
Robert C TrenschelDirectorMay 2022
Stephanie C DiazDirectorMay 2022
Thomas HallamDirectorMay 2022
David MazzoDirectorJan 2020
Kenneth CarterDirectorJan 2020
Sandford SmithDirectorJan 2020
Scott OgilvieDirectorJan 2020
Catherine SohnDirectorDec 2016
Richard DalyDirectorDec 2016
Stanley WestreichDirectorDec 2016

Went public since 2011. Its SEC number is that of a company listed on a stock exchange.